IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $827,753 | +1.6% | 82,037 | -0.2% | 0.04% | +59.3% |
| Q3 2022 | $815,000 | +1.1% | 82,200 | 0.0% | 0.03% | +8.0% |
| Q2 2022 | $806,000 | 0.0% | 82,200 | 0.0% | 0.02% | +13.6% |
| Q1 2022 | $806,000 | +0.9% | 82,200 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $799,000 | +0.3% | 82,200 | 0.0% | 0.02% | -18.5% |
| Q3 2021 | $797,000 | +0.3% | 82,200 | 0.0% | 0.03% | -10.0% |
| Q2 2021 | $795,000 | – | 82,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |